(Q39214783)

10 September 2017

title

MiR-199b-5p targets HER2 in breast cancer cells (English)

1 reference

10 September 2017

1 reference

Chen Fang

1

1 reference

10 September 2017

Yu Zhao

series ordinal

2

1 reference

10 September 2017

Baoyu Guo

series ordinal

3

1 reference

10 September 2017

publication date

1 July 2013

1 reference

Journal of Cellular Biochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

114

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

1457-1463

1 reference

ErbB2 down-regulates microRNA-205 in breast cancer

10 September 2017

cites work

1 reference

microRNAs: tiny regulators with great potential

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

21 January 2018

1 reference

Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.

21 January 2018

1 reference

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia

21 January 2018

1 reference

MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma

21 January 2018

1 reference

Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells

21 January 2018

1 reference

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer

21 January 2018

1 reference

Prediction of mammalian microRNA targets

21 January 2018

1 reference

Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL.

21 January 2018

1 reference

The roles of microRNA in cancer and apoptosis

21 January 2018

1 reference

Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation

21 January 2018

1 reference

Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

21 January 2018

1 reference

Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.

21 January 2018

1 reference

FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.

21 January 2018

1 reference

Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer.

21 January 2018

1 reference

Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation

21 January 2018

1 reference

Resistance to ErbB2 tyrosine kinase inhibitors in breast cancer is mediated by calcium-dependent activation of RelA.

21 January 2018

1 reference

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24487

1 reference

10 September 2017

1 reference